Bipolar disorder

• 1. Clinical Manifestations And Subtypes

  ›

  In 1954, Jules-Gabriel-François Baillarger described a biphasic mental illness causing recurrent oscillations between mania and melancholia to the French Imperial Académie Nationale de Médecine. This condition involves periods of depression lasting days to weeks, sometimes months, alternating with abnormally elevated moods. During these manic phases, an individual behaves or feels abnormally energetic, happy, or irritable, often making impulsive decisions with little regard for consequences. Sleep disturbance is usually present during manic phases, while depressive periods may feature crying, a negative outlook, and poor eye contact. The condition is classified as bipolar I disorder if there has been at least one manic episode, with or without depressive episodes. It becomes bipolar II disorder when there has been at least one hypomanic episode but no full manic episodes, alongside one major depressive episode. Cyclothymia describes cases where hypomanic episodes alternate with periods of depression that do not meet criteria for major depressive episodes. Approximately 60, 75% of people with bipolar I disorder have experienced psychosis, which includes delusions or hallucinations consistent with their mood state. Hypomania is defined as at least four consecutive days of elevated mood symptoms, whereas mania persists for more than a week. If untreated, a manic episode typically lasts three to six months.

  41827

• 2. Etiology And Biological Mechanisms

  ›

  Genetic factors account for up to 93% of the risk of developing bipolar disorder, indicating a strong hereditary component. Twin studies show concordance rates around 40% in identical twins compared to about 5% in fraternal twins for bipolar I disorder. Environmental risks include a history of child abuse and long-term stress, with 30, 50% of adults reporting traumatic experiences in childhood. Neuroimaging studies reveal differences in brain region volumes between patients and healthy controls, such as smaller left rostral anterior cingulate cortex and larger lateral ventricles. The ventral system regulates emotional perception while the dorsal system handles emotional regulation; dysfunction here may cause the disorder. Dopamine transmission increases during manic phases but decreases during depressive phases due to homeostatic downregulation. Glutamate levels rise significantly within the left dorsolateral prefrontal cortex during mania before returning to normal. In 2022, researchers identified the AKAP11 gene as the first gene linked to bipolar disorder through analysis of exomes from around 14,000 individuals. This gene interacts with the GSK3B protein, which is a molecular target of lithium.

  697582

• 3. Diagnostic Challenges And Differential Diagnosis

  ›

  Most people delay seeking treatment for an average of eight years after symptoms begin, often leading to initial misdiagnosis as major depression. Blood tests and imaging are carried out to investigate medical illnesses that mimic bipolar features, including multiple sclerosis, complex partial seizures, strokes, and brain tumors. Disorders like borderline personality disorder present sudden mood swings secondary to social stressors, contrasting with sustained changes over days or weeks seen in bipolar disorder. Endocrine disorders such as hypothyroidism, hyperthyroidism, and Cushing's disease also appear in differential diagnoses alongside infectious causes like herpes encephalitis or HIV. Certain medications can induce manic symptoms, including antidepressants, prednisone, Parkinson's disease drugs, thyroid hormone, stimulants, and antibiotics. The DSM-5 criteria require at least one manic episode for diagnosis, yet many affected individuals are initially treated with prescribed antidepressants. Estimates vary widely about how many children have bipolar disorder, ranging from 0.6% to 15%, raising suspicions of both underdiagnosis and overdiagnosis depending on the setting and method used.

  606263

• 4. Pharmacological Treatments And Therapies

  ›

  Lithium is considered the most effective medication for acute manic episodes, preventing relapses, and reducing suicide risk, self-harm, and death. Mood stabilizers include carbamazepine, lamotrigine, and valproic acid, each with varying efficacy profiles regarding mania prevention versus depression treatment. Atypical antipsychotics like lurasidone, quetiapine, olanzapine-fluoxetine combination, cariprazine, and lumateperone are FDA approved specifically for treating bipolar depression. Electroconvulsive therapy proves effective for acute mood disturbances, especially when psychotic or catatonic features are present. Antidepressant monotherapy does not provide benefit over mood stabilizers and may increase risks of affective switches or rapid cycling. Valproate and carbamazepine are teratogenic and should be avoided in women of childbearing age due to high risks during pregnancy. More than 75% of individuals inconsistently take their medications for various reasons, significantly impacting prognosis. Cognitive behavioral therapy, family-focused therapy, and psychoeducation have the strongest evidence for relapse prevention among psychosocial interventions.

  19204350

• 5. Prognosis And Public Health Impact

  ›

  Bipolar disorder ranks as the sixth leading cause of disability worldwide, affecting approximately 1 to 3% of the general population. The annual average suicide rate ranges from 0.4% to 1.4%, which is thirty to sixty times greater than that of the general population. An estimated 15, 20% of those with the condition die by suicide, while 30, 60% attempt it during their lifetime. People with bipolar disorder face a risk of death from natural causes twice the average, largely due to cardiovascular disease and metabolic syndrome. In 2015, the United States spent approximately $202.1 billion on people diagnosed with bipolar I disorder alone. Homelessness prevalence reaches around 8% among homeless individuals globally, several times higher than population averages. One-third of people remain unemployed for one year following hospitalization for mania, contributing to substantial societal costs and lost productivity. Two-thirds continue to experience impaired psychosocial functioning even when mood symptoms are in full remission.

  91035

• 6. Historical Evolution Of The Concept

  ›

  In 1850, Jean-Pierre Falret described circular insanity, with his lecture summarized in 1851 in the Hospital Gazette. Three years later, Jules-Gabriel-François Baillarger presented madness in double form to the French Imperial Académie Nationale de Médecine. German psychiatrist Emil Kraepelin coined the term manic depressive psychosis after noting periods of acute illness punctuated by symptom-free intervals where patients could function normally. The term manic-depressive reaction appeared in the first version of the DSM in 1952, influenced by Adolf Meyer's legacy. Subtyping into unipolar and bipolar disorders originated with Karl Kleist's concept from 1911, used by Karl Leonhard in 1957 to differentiate conditions. Bipolar II and rapid cycling subtypes were included since the DSM-IV, based on work from the 1970s by David Dunner, Elliot Gershon, Frederick Goodwin, Ronald Fieve, and Joseph Fleiss. These historical developments established the modern framework for understanding the disorder as a spectrum rather than a single entity.

• 7. Social Stigma And Cultural Representation

  ›

  In 2000, actress Carrie Fisher went public with her diagnosis, becoming one of the most recognized advocates for eliminating stigma surrounding mental illnesses. Actor Stephen Fry pushed awareness through his 2006 documentary Stephen Fry: The Secret Life of the Manic Depressive after being diagnosed at age thirty-seven. Singer Rosemary Clooney served as an early celebrity spokesperson for mental illness before others like Catherine Zeta-Jones and Mariah Carey followed suit. Kay Redfield Jamison profiled her own experience in the memoir An Unquiet Mind published in 1995. Dramatic works such as Mr. Jones (1993) and The Mosquito Coast (1986) have portrayed characters displaying traits suggestive of the diagnosis. Psychiatrists suggest Willy Loman, the main character in Arthur Miller's play Death of a Salesman, may also exhibit bipolar disorder features. Despite these cultural representations, widespread issues with social stigma, stereotypes, and prejudice persist against individuals receiving this diagnosis.